![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Financial & competing interests disclosure
SC Dudley is the inventor on patent applications: Activation of the Renin–Angiotensin System (RAS) and Sudden Cardiac Death, 13/032,629; Modulating Mitochondrial Reactive Oxygen Species to Increase Cardiac Sodium Channel Current and Mitigate Sudden Death, 12/929,786; Method for Ameliorating or Preventing Arrhythmic Risk Associated with Cardiomyopathy by Improving Conduction Velocity, 13/551,790; Method for Modulating or Controlling Connexin 43 (Cx43) Level of a Cell and Reducing Arrhythmic Risk, 13/507,319; Modulation of Sodium Channels by Nicotinamide Adenine Dinucleotide, 8,003,324 and Method for Modulating or Controlling Sodium Channel Current by Reactive Oxygen Species (ROS) Originating From Mitochondria, 20110144192.
The authors were supported by NIH grants P01 HL058000, R01 HL1024025, R01 HL106592, Veterans Administration Merit Award and R41 HL112355 (S Dudley). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.